Scinovia on StartEngine
Health & WellnessTech

Scinovia

Point-and-Image to Know-the-Flow
Raleigh, 
NC
Investment type:
Equity
(Common)
Target raise:
$9,998
 - $1,070,000
Minimum investment:​
$499
End date:
Apr 29, 2022
ended
Our Story

Scinovia’s mission is to produce state-of-the-art diagnostics to help doctors make more data-driven decisions during procedures to save more lives. Scinovia developed VUFLOW, the future of non-contact imaging diagnostics for blood flow during surgery.
Our Ambition

Assessing the blood flow for surgery is challenging and costly. A top challenge surgeons face is knowing whether a procedure has poor blood flow. The number one problem surgeons face is knowing whether a procedure has poor blood flow. 20% of bypass grafts have less than 50% of average blood flow and 14% of breast reconstruction have necrosis. These cases add up: it costs around $100k per case to address breast tissue necrosis.